Both in Pharmaceuticals
Nomad Power Solutions vs Rein Therapeutics
Over the past year NMAD returned +1.7% and RNTX returned −16.1%; their daily moves had a correlation of 0.16.
NMAD +1.7% RNTX −16.1%Growth of $1, one year, split-adjusted
| Metric | NMAD | RNTX |
|---|---|---|
| Price | $3.60 | $0.6587 |
| Market cap | $58.0M | $56.8M |
| Today | +2.27% | −1.32% |
| 1 month | −17.1% | −20.2% |
| 6 months | — | −43.7% |
| Year to date | — | −43.2% |
| 1 year | — | −62.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 95.8% |
| Short % of float | 11.0% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).